Total Payments
$2,239
2023 Payments
$311.71
Companies
12
Transactions
135
Medicare Patients
1,114
Medicare Billing
$80,395
Payment Breakdown by Category
Food & Beverage$2,162 (96.6%)
Education$77.00 (3.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,162 | 134 | 96.6% |
| Education | $77.00 | 1 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $383.06 | 21 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $378.50 | 26 | $0 (2023) |
| PFIZER INC. | $375.93 | 27 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $213.57 | 7 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $203.70 | 14 | $0 (2023) |
| Amgen Inc. | $202.37 | 13 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $188.71 | 13 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $112.48 | 3 | $0 (2022) |
| Merck Sharp & Dohme LLC | $93.68 | 6 | $0 (2022) |
| Amarin Pharma Inc. | $41.57 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $311.71 | 19 | Novartis Pharmaceuticals Corporation ($66.14) |
| 2022 | $1,135 | 64 | Janssen Pharmaceuticals, Inc ($191.01) |
| 2021 | $792.31 | 52 | PFIZER INC. ($230.58) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $29.46 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/14/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/16/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Cardiology | ||||||
| 05/10/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: DIABETES | ||||||
| 04/17/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Cardiology | ||||||
| 04/04/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/29/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/27/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| 03/15/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/22/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/14/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Cardiology | ||||||
| 02/08/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.40 | General |
| Category: Cardiovascular | ||||||
| 02/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/01/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.92 | General |
| Category: Cardiovascular | ||||||
| 01/25/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/18/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/11/2023 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/09/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/07/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Cardiology | ||||||
| 12/06/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/30/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 261 | 350 | $76,052 | $20,359 |
| 2022 | 1 | 206 | 256 | $54,784 | $14,985 |
| 2021 | 2 | 269 | 317 | $71,078 | $19,236 |
| 2020 | 7 | 378 | 424 | $96,457 | $25,816 |
Total Patients
1,114
Total Services
1,347
Medicare Billing
$80,395
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 249 | 338 | $72,332 | $19,315 | 26.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,720 | $1,044 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 206 | 256 | $54,784 | $14,985 | 27.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 224 | 272 | $57,128 | $15,240 | 26.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 45 | 45 | $13,950 | $3,995 | 28.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 205 | 239 | $42,657 | $11,118 | 26.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 54 | 61 | $18,910 | $5,702 | 30.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 33 | 33 | $12,606 | $3,449 | 27.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 24 | 24 | $7,032 | $1,743 | 24.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $5,508 | $1,652 | 30.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 22 | $3,630 | $1,081 | 29.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 18 | $4,374 | $581.31 | 13.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 14 | 15 | $1,740 | $489.08 | 28.1% |
About Janet Hicks, FNP-C
Janet Hicks, FNP-C is a Family healthcare provider based in Glen Dale, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2016. The National Provider Identifier (NPI) number assigned to this provider is 1568816072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Janet Hicks, FNP-C has received a total of $2,239 in payments from pharmaceutical and medical device companies, with $311.71 received in 2023. These payments were reported across 135 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,162).
As a Medicare-enrolled provider, Hicks has provided services to 1,114 Medicare beneficiaries, totaling 1,347 services with total Medicare billing of $80,395. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.